{"id":295437,"date":"2024-07-25T13:00:00","date_gmt":"2024-07-25T13:00:00","guid":{"rendered":"http:\/\/www.cheln.com\/index.php\/2024\/07\/25\/ffce9699067970afd44e77015ebff220"},"modified":"2024-07-25T13:00:00","modified_gmt":"2024-07-25T13:00:00","slug":"ffce9699067970afd44e77015ebff220","status":"publish","type":"post","link":"http:\/\/www.cheln.com\/index.php\/2024\/07\/25\/ffce9699067970afd44e77015ebff220\/","title":{"rendered":"PHASE III ARCADIA 1 and 2 Trial Primary Results Published in The Lancet: Galderma\u300fs Nemolizumab Improves Key Aspects of Atopic Dermatitis \u2013 Itch, Skin Lesions and Sleep Disturbance
"},"content":{"rendered":"
\"\u9996\u5716\" ZUG, Switzerland–(BUSINESS WIRE)–Galderma today announced that full results from the phase III ARCADIA 1 and 2 clinical trials in atopic dermatitis were published in The Lancet.1The tria…<\/div>\n